Artisan Partners’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $703M | Sell |
2,634,024
-596,164
| -18% | -$139M | 1.11% | 21 |
|
|
2026
Q1 | $739M | Buy |
3,230,188
+4,303
| +0.1% | +$965K | 1.19% | 23 |
|
|
2025
Q4 | $688M | Sell |
3,225,885
-494,995
| -13% | -$102M | 1.03% | 23 |
|
|
2025
Q3 | $740M | Sell |
3,720,880
-269,544
| -7% | -$50.3M | 1.05% | 24 |
|
|
2025
Q2 | $689M | Sell |
3,990,424
-266,203
| -6% | -$43.4M | 1.01% | 29 |
|
|
2025
Q1 | $663M | Sell |
4,256,627
-193,793
| -4% | -$27.7M | 1.07% | 23 |
|
|
2024
Q4 | $613M | Buy |
4,450,420
+39,309
| +0.9% | +$5.17M | 0.92% | 27 |
|
|
2024
Q3 | $659M | Buy |
4,411,111
+116,082
| +3% | +$15.7M | 0.98% | 26 |
|
|
2024
Q2 | $586M | Sell |
4,295,029
-1,376,905
| -24% | -$187M | 0.88% | 35 |
|
|
2024
Q1 | $857M | Sell |
5,671,934
-77,293
| -1% | -$11M | 1.24% | 24 |
|
|
2023
Q4 | $724M | Sell |
5,749,227
-246,181
| -4% | -$24.5M | 1.11% | 24 |
|
|
2023
Q3 | $561M | Sell |
5,995,408
-227,043
| -4% | -$21.2M | 0.95% | 28 |
|
|
2023
Q2 | $555M | Sell |
6,222,451
-622,290
| -9% | -$54.2M | 0.89% | 34 |
|
|
2023
Q1 | $734M | Sell |
6,844,741
-75,615
| -1% | -$8.65M | 1.21% | 21 |
|
|
2022
Q4 | $845M | Sell |
6,920,356
-229,137
| -3% | -$26.6M | 1.49% | 13 |
|
|
2022
Q3 | $738M | Sell |
7,149,493
-323,593
| -4% | -$30.7M | 1.3% | 17 |
|
|
2022
Q2 | $695M | Sell |
7,473,086
-739,852
| -9% | -$69.7M | 1.17% | 20 |
|
|
2022
Q1 | $964M | Buy |
8,212,938
+272,504
| +3% | +$31.6M | 1.27% | 17 |
|
|
2021
Q4 | $1.07B | Buy |
7,940,434
+155,574
| +2% | +$23.1M | 1.27% | 16 |
|
|
2021
Q3 | $1.24B | Buy |
7,784,860
+1,355,453
| +21% | +$186M | 1.51% | 8 |
|
|
2021
Q2 | $846M | Buy |
6,429,407
+382,517
| +6% | +$51M | 1.01% | 29 |
|
|
2021
Q1 | $779M | Buy |
6,046,890
+279,363
| +5% | +$42.5M | 0.99% | 31 |
|
|
2020
Q4 | $962M | Buy |
5,767,527
+152,310
| +3% | +$25.2M | 1.17% | 14 |
|
|
2020
Q3 | $867M | Buy |
5,615,217
+1,583,713
| +39% | +$228M | 1.22% | 16 |
|
|
2020
Q2 | $596M | Buy |
4,031,504
+1,472,148
| +58% | +$202M | 0.96% | 29 |
|
|
2020
Q1 | $288M | Buy |
2,559,356
+402,960
| +19% | +$52.4M | 0.62% | 52 |
|
|
2019
Q4 | $300M | Buy |
2,156,396
+16,731
| +0.8% | +$1.86M | 0.53% | 58 |
|
|
2019
Q3 | $206M | Buy |
2,139,665
+546,398
| +34% | +$61M | 0.39% | 67 |
|
|
2019
Q2 | $183M | Buy |
1,593,267
+462,160
| +41% | +$55.3M | 0.34% | 73 |
|
|
2019
Q1 | $133M | Buy |
1,131,107
+764,160
| +208% | +$66.9M | 0.26% | 79 |
|
|
2018
Q4 | $23M | Buy |
366,947
+135,275
| +58% | +$8.5M | 0.05% | 209 |
|
|
2018
Q3 | $16.4M | Buy |
231,672
+144,561
| +166% | +$9.95M | 0.03% | 220 |
|
|
2018
Q2 | $5.79M | Buy |
+87,111
| New | +$5.73M | 0.01% | 245 |
|
Other funds holding ASND
RCM
ACA
JT
Artisan Partners's ASND Position: Q2 2026 in Review
Artisan Partners reduced its Ascendis Pharma A/S (ASND) stake by 18% in Q2 2026, selling an estimated $139M and leaving 2,634,024 shares worth $703M. The position accounts for 1.11% of the portfolio, ranked #21.
Artisan Partners first reported a position in ASND in Q2 2018 and has held it in 33 quarters since. The position peaked at $1.24B in Q3 2021. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.
- Artisan Partners held 2,634,024 shares of Ascendis Pharma A/S worth $703M as of Q2 2026.
- Artisan Partners sold 596,164 Ascendis Pharma A/S shares in Q2 2026, an estimated $139M.
- Ascendis Pharma A/S made up 1.11% of Artisan Partners's portfolio in Q2 2026, its #21 holding.
- Artisan Partners first reported a position in Ascendis Pharma A/S in Q2 2018 and has held it in 33 quarters since.
- Artisan Partners's Ascendis Pharma A/S position peaked at $1.24B in Q3 2021.
- 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.
Based on Artisan Partners's 13F filing for Q2 2026, filed 13 Aug 2026.